The online GLP-1 market has grown dramatically since 2022, and with it, the number of platforms competing for the business of people looking for physician-prescribed semaglutide or tirzepatide. For patients, this growth is mostly good news: access has improved and prices have come down significantly relative to brand-name alternatives. The downside is that it's harder to evaluate what separates these programs from each other when the surface-level pitch sounds identical.

This comparison covers the major categories that actually determine whether a GLP-1 telehealth program works for you over the long term: physician oversight quality, medication formulation, community and support features, cost structure, and program design.

A note upfront: EllieMD publishes this article and is included in the comparison. We've tried to represent each platform's actual offering accurately and to be clear about where EllieMD has advantages and where it doesn't. Verify current details directly with any platform before subscribing, as pricing and program features change.

Before comparing platforms, it helps to know what variables actually matter.

Physician oversight. The initial consultation matters, but so does ongoing access. What happens when you have side effects? Can you reach a physician or only a support chatbot? How does the platform handle dose adjustments?

Medication quality. All the major platforms use compounded semaglutide or tirzepatide from licensed pharmacies. But not all pharmacies are equivalent. Asking about pharmacy credentials, the form of semaglutide used (base vs. salt forms), and testing standards is reasonable.

Program structure. A prescription alone is not a weight loss program. Does the platform offer anything beyond the medication? Dietary guidance, community support, accountability features, and progress monitoring all affect long-term outcomes.

Cost transparency. Some platforms have a low-entry price with fees that emerge later. Others have simpler subscription models. Understanding total monthly cost, including consultation fees and medication, is important.

Regulatory compliance. Given ongoing FDA attention to compounded GLP-1 medications, platforms that are transparent about their regulatory approach and pharmacy partnerships are preferable.

Hims is the largest player in this market by revenue. Its GLP-1 program offers compounded semaglutide with a straightforward subscription model, brand recognition, and efficient onboarding.

Strengths: Scale, brand recognition, competitive pricing, and a broad product range if you want multiple telehealth services in one place.

Considerations: Ongoing physician access is limited compared to platforms designed specifically around weight loss management. Community features are minimal. The program is primarily transactional.

Best for: People who want a simple, efficient semaglutide prescription from a trusted brand and plan to manage their program primarily independently.

Ro offers its "Body" program with compounded semaglutide and has positioned itself as a more clinically sophisticated telehealth option. Its medical team and content are well-regarded.

Strengths: Clinical rigor, well-produced educational content, and pharmacy partnerships that meet strong quality standards. The platform has been thoughtful about regulatory compliance.

Considerations: Higher price point than some competitors. Limited community or accountability features.

Best for: Patients who prioritize clinical quality and are willing to pay a premium for it, and who don't need community support features.

LifeMD operates as a full-service telehealth company with a strong GLP-1 offering. It has built a significant content library around GLP-1 education and positions its program around comprehensive support.

Strengths: Good content, established telehealth infrastructure, and a reasonably comprehensive program design.

Considerations: Program quality can vary by state and provider. Less differentiated than some competitors in terms of unique program features.

Best for: Patients in the mid-market looking for a complete program without a premium price.

Mochi positions itself specifically as an obesity medicine platform, which means its clinical approach is more explicitly weight-science-focused than general telehealth platforms. It integrates insurance billing, which is a meaningful differentiator.

Strengths: Insurance integration is genuinely useful for patients with coverage for GLP-1 medications. Clinical focus on obesity medicine specifically.

Considerations: Insurance-dependent model means the experience can vary significantly based on your plan. Less accessible for patients without relevant coverage.

Best for: Patients with insurance coverage that includes GLP-1 obesity medications.

EllieMD's weight loss program uses compounded semaglutide combined with L-carnitine in a formulation designed to support both appetite reduction and fat oxidation. The program includes physician oversight throughout the treatment period, not just at the initial consultation.

The distinctive feature of EllieMD is its community model. Research from Northwestern University and other sources has consistently shown that social support and accountability improve long-term weight loss outcomes significantly compared to individual approaches. EllieMD is built around this principle. Members have access to a community of over 200,000 people at various stages of their weight loss journey, with facilitated interaction rather than just a passive forum.

EllieMD also offers a microdosing program specifically for patients who want a lower-dose, more gradual approach, which is unusual among telehealth GLP-1 platforms.

Strengths: Community model backed by research, accessible physician oversight, distinctive formulation, and a program designed for patients who want more than just a prescription.

Considerations: The community-centric model is valuable for people who engage with it. Patients who want a purely transactional experience may find the model more than they need.

Best for: Patients who have struggled with adherence in previous weight loss attempts, who want ongoing physician access, and who believe community support will make a difference in their long-term outcomes.

The best online GLP-1 program for you depends on a few honest self-assessments.

If you'll stay adherent independently and want simplicity: Hims or Ro fit that profile. The prescription gets dispensed, you manage your own journey, and you call it success or failure based on your own discipline.

If you've tried GLP-1 therapy or other weight loss approaches before and struggled with staying the course: the community accountability model that EllieMD offers addresses the most common reason for dropout. Side effects, motivation fading, and lack of accountability are all addressed within that structure.

If insurance coverage is your primary concern: Mochi's model is worth exploring if your plan covers GLP-1 for obesity.

If clinical rigor is your priority: Ro's approach to pharmacy partnerships and clinical content is well-regarded.

The platforms that last longest for most patients are the ones that address the full behavioral context of weight loss, not just the prescription. A GLP-1 medication dramatically improves the odds of success. The support structure around it determines how long those odds hold up.

Every platform on this list uses a licensed physician consultation process, compounded semaglutide or tirzepatide from licensed pharmacies, and delivery by mail. The active ingredient is the same across all of them. The differentiation comes from everything wrapped around that medication.

Side effects occur on any GLP-1 program. The platforms that help patients manage those side effects effectively and stay on treatment are the ones that produce better outcomes over time.


Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.